Ep-CAM is overexpressed in various epithelial cancers [7] and is an ideal therapeutic target because of the following reasons: (a) overexpression in cancer cells versus noncancerous cells, (b) apical expression in cancer cells and basolateral expression in normal epithelial cells [8], and (c) not shed into the circulation [9]. Here, EPCAM is linked to cancer.